Doxazosin Tablet
Product Images NDC 68071-3811

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 68071-3811). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3811 6)

This is a detailed description of a pharmaceutical product named Doxazosin 2mg produced by NuCare Pharmaceuticals, Inc. The tablets are light pink to pink in color and are scored for easy splitting. Each tablet contains 2mg of Doxazosin. The packaging includes lot numbers, expiration dates, and serial numbers for identification purposes. The product is intended for prescription use only and it's important to consult a doctor for medical advice and report any side effects to the FDA. The storage conditions recommend keeping the product at a controlled temperature between 68-77°F and to keep it out of reach of children.*

FDA Label Image

Doxazosin Tablets, Usp (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 01)

FDA Label Image

Doxazosin Tablets (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 02)

This text seems to describe a study evaluating the effectiveness of Dorazosin in the treatment of benign prostatic hyperplasia (BPH). The text presents data on symptom scores, rates of change, and dosing regimens in three different study phases. The study results indicate potential benefits of Dorazosin compared to a placebo in improving symptoms associated with BPH.*

FDA Label Image

Doxazosin Tablets, Usp (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 03)

This text provides information about the mean change in peak urinary flow rate from baseline. It compares the results of using a medication called Doxazosin-Titration to a placebo. The text also mentions significance levels in the comparison, such as p<0.006 compared to Placebo and p<0.005 compared to Baseline. The dosage of Doxazosin-Titration used was up to a maximum of 8g.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.